Haoyang Zheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Haoyang Zheng has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Jiashu Zhang
Department of Neurosurgery, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China
1 shared publication - Qun Wang
Department of Neurosurgery, First Medical Center of Chinese PLA General Hospital, Beijing 100853, China
1 shared publication - Shiyu Zhang
Department of Neurosurgery, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China
1 shared publication - Xiaolei Chen
Department of Neurosurgery, the First Medical Center, Chinese PLA General Hospital, Beijing, China
1 shared publication - Xinghua Xu
Department of Neurosurgery, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China
1 shared publication - Zhichao Gan
Department of Neurosurgery, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China
1 shared publication
Latest Publications
- Open Access
- 10 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (14) , 5403
Artificial Intelligence in Intracerebral Hemorrhage: Current Applications and Future Perspectives
Intracerebral hemorrhage (ICH) remains one of the most severe forms of stroke and is associated with high mortality, poor functional outcomes, and substantial healthcare burden worldwide. Despite advances in neurocritical care and minimally invasive surgical techniques, the management of ICH remains challenging because of disease heterogeneity, rapid neurological deterioration, and the lack of effective individualized treatment strategies. In recent years, artificial intelligence (AI) has emerged as a promising tool for improving the diagnosis, prognostic evaluation, and precision management of ICH. A systematic literature search was performed in PubMed, Web of Science, and Embase to identify studies on AI applications in ICH, with predefined inclusion criteria focusing on imaging analysis, prognostic prediction, clinical decision support, and minimally invasive surgery. This review summarizes the major clinical applications, limitations, and future directions of AI in ICH, including multimodal foundation models, intelligent surgical assistance, and personalized precision care. Recent studies have demonstrated that AI-based models can significantly improve the accuracy of hematoma segmentation, hematoma expansion prediction, and functional outcome prognostication compared with conventional approaches. Despite encouraging progress, several important barriers continue to limit clinical translation, including data heterogeneity, limited external validation, insufficient interpretability, ethical and regulatory concerns, and challenges in workflow integration. Overall, AI has the potential to transform ICH management from conventional experience-based practice to data-driven, personalized, and precision neurosurgical care.
- 10 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (14) , 5403
Open AccessArtificial Intelligence in Intracerebral Hemorrhage: Current Applications and Future Perspectives
Intracerebral hemorrhage (ICH) remains one of the most severe forms of stroke and is associated with high mortality, poor functional outcomes, and substantial healthcare burden worldwide. Despite advances in neurocritical care and minimally invasive surgical techniques, the management of ICH remains challenging because of disease heterogeneity, rapid neurological deterioration, and the lack of effective individualized treatment strategies. In recent years, artificial intelligence (AI) has emerged as a promising tool for improving the diagnosis, prognostic evaluation, and precision management of ICH. A systematic literature search was performed in PubMed, Web of Science, and Embase to identify studies on AI applications in ICH, with predefined inclusion criteria focusing on imaging analysis, prognostic prediction, clinical decision support, and minimally invasive surgery. This review summarizes the major clinical applications, limitations, and future directions of AI in ICH, including multimodal foundation models, intelligent surgical assistance, and personalized precision care. Recent studies have demonstrated that AI-based models can significantly improve the accuracy of hematoma segmentation, hematoma expansion prediction, and functional outcome prognostication compared with conventional approaches. Despite encouraging progress, several important barriers continue to limit clinical translation, including data heterogeneity, limited external validation, insufficient interpretability, ethical and regulatory concerns, and challenges in workflow integration. Overall, AI has the potential to transform ICH management from conventional experience-based practice to data-driven, personalized, and precision neurosurgical care.